News
August 30, 2023
MedVasc selected to join accelerator powered by Medtronic
MedVasc has been selected to join prestigious medtech ac MedVasc has been selected as 1 of 11 international medtech startups to learn from Medtronic and MedLim partners how to accelerate commercialization. It all kicked off with a fantastic week in Maastricht followed by digital sessions and 1-1 meetings. “We feel humble and grateful for the opportunity. It’s been a…
August 30, 2023
Successful closing of SEK 3 million investment round
MedVasc has closed an investment round of 3 M SEK. The investors include several Life science investors such as Life Science Invest Gamma, but also existing and new private investors. The raised capital will mainly be used for final product development and for preparing an FDA 510k application for…
January 20, 2023
Medvasc’s patent portfolio has been granted in key licensing markets
In the fall of 2022, the patent authorities of India, Canada, and Brazil announced that they intend to grant MedVasc’s patent. MedVasc’s patent portfolio is strengthened by the announcements relating to the company’s medical device, the anesthesia catheter SolutioTM. SolutioTM minimizes the pain when performing the gold standard treatment…
September 12, 2022
Medvasc presenterar lyckade studieresultat på internationell kongress
Medicinteknikbolaget MedVascs vd och grundare, Michael Åkesson, har accepterats som talare vid årets mest betydelsefulla internationella symposium för forskare, specialistläkare och medicinteknikindustri inom hjärt- och kärlsjukdomar. Läs mer här…
September 12, 2022
Medvasc ab has appointed a new ceo – and strengthened the board with a high-profile life science executive
As the next step in MedVasc’s journey towards commercialization of the medical device Solutio™ in the US and European markets, the company has appointed Cathrin Johansson as new CEO and Eric Wahlberg as new Chair of the Board. Read more here!…
For press inquiries, please send an email
Subscribe to our newsletter
For more information on how we process your personal data please see our Privacy Notice
